Investors

Neurogastrx has raised a total of $125M in financing to date.

OrbiMed
venBio
Vivo
rtw
mw
Neurogastrx, Inc.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.